This hypothesis gave birth to an entire family of short regulatory peptides (Semax, Selank, Cortexin, Noopept, Epitalon, Cerluten and dozens of others) whose synthesis is documented in Russian pharmacological literature
I don't even know where to begin, my experience with Dr Williams has been an amazing one from start to finish
Retatrutide, designated LY3437943, is a triple agonist targeting GIP, GLP-1, and glucagon receptors simultaneously
Concurrent use is not recommended because both drugs act on the GLP-1 receptor simultaneously, increasing nausea and GI side effect risk significantly
Hepatokines may offer therapeutic benefits by mitigating oxidative stress and restoring mitochondrial function